NEW YORK (GenomeWeb News) – Roche today reported that its molecular diagnostics sales rose 5 percent and its applied science revenues increased 8 percent year over year for the first half of 2009.
The Swiss pharmaceuticals, diagnostics, and life sciences firm reported molecular diagnostic sales of CHF594 million (US$553.8 million), up 5 percent, while its applied science business brought in revenues of CHF 403 million, an increase of 8 percent year over year.